AAAmudha Aravindhan

Amudha Aravindhan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Amudha Aravindhan has a total of 14 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Understanding the Prevalence, Factors, and Patient-Centered and Economic Outcomes of Prefrailty and Frailty in Community-Dwelling Older Singaporean Adults

    by Ryan E. K. Man, Preeti Gupta, Chiew Meng Johnny Wong, Aurora W. D. Chan, Eva K. Fenwick, Amudha Aravindhan, Junxing Chay, Samuel Teong Huang Chew, Laura Tay, Yee Sien Ng, et al.

    Introduction: The objective of this study was to determine the prevalence, factors associated with, and patient-centered and economic outcomes of prefrailty and frailty in a multi-ethnic population of community-dwelling older Singaporean adults aged ≥60 years. Methods: We included 2110 participants (mean age ± SD: 72.4 ± 8.1 years; 52.6% female) from the cross-sectional Population Health and Eye Disease Profile in Elderly Singaporeans (PIONEER) study (2017 to 2022). A modified Fried frailty cross-sectional phenotype classification was used to categorize participants as prefrail or frail, based on them having 1–2 or ≥3 of the following characteristics: underweight (body mass index < 18.5 kg/m2), slowness (sex-specific lowest quintile of time taken to complete a 4 m gait speed test), weakness (sex-specific lowest quintile of grip strength), self-reported exhaustion (score < 10 in the Vitality domain of the 12-item short-form survey), and low physical activity duration (sex-specific lowest quintile of those individuals a non-zero duration). Sociodemographic, clinical and lifestyle factors, patient-centered (health-related quality of life, functional disability, life-space mobility, depressive symptoms, falls and perceived economic hardship) and economic (healthcare expenditure, work productivity loss) outcomes were assessed via standardized clinical testing and/or validated questionnaires. Ordinal logistic regression models with dominance analysis, linear, negative binomial and two-part regression models were utilized to explore the associated factors and patient-centered and economic outcomes of prefrailty and frailty, respectively. Results: The census-adjusted prevalence of prefrailty and frailty were 64.6% and 11.0%, respectively. Age, minority ethnicity, and cognitive impairment contributed ≥70% of the total model effect, with the remaining contributors being female sex, diabetes, and polypharmacy. The frailty severity spectrum (none, prefrailty and frailty) were also associated with 1.74% to 164.49% significantly poorer outcomes across the majority of patient-centered outcomes assessed. No significant overall differences in annual healthcare expenditure and productivity loss were observed. Conclusions: Over half and one in ten of community-dwelling older Singaporeans were prefrail and frail, respectively, with both groups experiencing substantially poorer patient-centered outcomes. Older age, female sex and cognitive impairment were associated with greater odds of presenting along the frailty severity spectrum and warrants further verification through longitudinal investigations.